Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care.
The successful topical treatment of chronic wounds requires adequate debridement, bacterial balance, and moisture balance. An ionized nanocrystalline silver dressing was evaluated through an uncontrolled, prospective study of a case series of 29 patients with a variety of chronic nonhealing wounds. The four arms of the study included nine patients with foot ulcers, six patients with venous stasis ulcers, two patients with pressure ulcers, and 12 patients with miscellaneous wounds. All wounds were assessed for the usual signs of clinical infection, with most of these parameters being measured and recorded. Microbiologically, bacterial load was determined via quantitative biopsies and semi-quantitative swabs. In general, the results showed a marked clinical improvement for the majority of wounds treated with the dressing. Among improved parameters included decreased exudate and decreased purulence. The quantitative bacterial biopsies did not show any decrease in organism numbers, although the semi-quantitative swabs indicated a decrease in the wound surface bacterial loading. This was indicative of the dressing's ability to reduce surface bacteria and achieve an element of bacterial balance in the superficial dermal compartment. The proposed mechanism of action for this ionized nanocrystalline based dressing is through bacterial and moisture balance within the superficial wound space compartment.
Sibbald
R G
RG
University of Toronto, Toronto, Canada. gary.sibbald@utoronto.ca
Browne
A C
AC
Coutts
P
P
Queen
D
D
D000465:Algorithms; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001706:Biopsy; D002626:Chemistry, Pharmaceutical; D002908:Chronic Disease; D003646:Debridement; D003663:Decision Trees; D005122:Exudates and Transudates; D006801:Humans; D036103:Nanotechnology; D009730:Nursing Assessment; D011091:Polyesters / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D011095:Polyethylenes / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D011446:Prospective Studies; D013492:Suppuration; D016896:Treatment Outcome; D014945:Wound Healing; D014946:Wound Infection / Q000382:microbiology / Q000473:pathology / Q000628:therapy*; D014947:Wounds and Injuries / Q000382:microbiology / Q000473:pathology / Q000628:therapy*
C117408:Acticoat; D000891:Anti-Infective Agents, Local; D011091:Polyesters; D011095:Polyethylenes